There has been much discussion throughout the healthcare industry about providing a positive patient experience and encouraging patients to have more of a voice in their treatment options. Stakeholders have come to recognize that patients have valuable information to share about their experiences with diseases and medications, which should influence drug approvals and treatment decisions. The FDA, for example, has launched an initiative, “The Voice of the Patient,” to gather patient perspectives across specific disease areas. The initiative allows the FDA to hear from patients directly about their conditions and the therapies they…
Mark Wade, Director, Patient Focused Solutions, Almac. The Almac Group is an established contract development and manufacturing organization that provides an extensive range of integrated services to over 600 companies globally within the pharmaceutical and biotech sectors. The services range from R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply, IXRS technology (IVRS/IWRS) through to commercial-scale manufacture. The international company is a privately owned organization that has organically grown over 30 years and now employs in excess of 3,300 highly skilled personnel. Almac is headquartered in Craigavon, Northern Ireland, with US operations based in Pennsylvania, North Carolina, and California, and in Asia (Singapore and Tokyo). For more information visit, almacgroup.com or email firstname.lastname@example.org.